TCM
TECX

Tekla Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Tekla Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,715
Closed -$2.45M – 222
2020
Q2 		$2.45M Buy
11,715
+5,475
+88% +$1.13M 0.09% 151
2020
Q1 		$1.17M Hold
6,240
– – 0.05% 168
2019
Q4 		$1.51M Buy
6,240
+4,559
+271% +$879K 0.06% 164
2019
Q3 		$285K Buy
+1,681
New +$381K 0.01% 179

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Tekla Capital Management's TECX Position: Q3 2020 in Review

Tekla Capital Management sold out of Tectonic Therapeutic (TECX) in Q3 2020, closing a stake of 11,715 shares — an estimated $2.45M sold.

Tekla Capital Management first reported a position in TECX in Q3 2019 and held it in 4 quarters. The position peaked at $2.45M in Q2 2020. 101 funds tracked by Wall St. Rank hold TECX as of Q3 2020.

  • Tekla Capital Management reported no remaining Tectonic Therapeutic position as of Q3 2020 after selling out during the quarter.
  • Tekla Capital Management sold 11,715 Tectonic Therapeutic shares in Q3 2020, an estimated $2.45M.
  • Tekla Capital Management first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 4 quarters.
  • Tekla Capital Management's Tectonic Therapeutic position peaked at $2.45M in Q2 2020.
  • 101 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.